{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:06:14Z","timestamp":1778648774071,"version":"3.51.4"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009054","name":"U.S. President\u2019s Emergency Plan for AIDS Relief","doi-asserted-by":"publisher","award":["NU2GGH001629"],"award-info":[{"award-number":["NU2GGH001629"]}],"id":[{"id":"10.13039\/100009054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0241071","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T18:46:26Z","timestamp":1604515586000},"page":"e0241071","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["HIV drug resistance profile in South Africa: Findings and implications from the 2017 national HIV household survey"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5296-3242","authenticated-orcid":true,"given":"Sizulu","family":"Moyo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8933-0628","authenticated-orcid":true,"given":"Gillian","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khangelani","family":"Zuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mpumi","family":"Zungu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmore","family":"Marinda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Musawenkosi","family":"Mabaso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibha","family":"Kana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monalisa","family":"Kalimashe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Ledwaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7590-0618","authenticated-orcid":true,"given":"Inbarani","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinovuyo","family":"Takatshana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tebogo","family":"Matjokotja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot","family":"Raizes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karidia","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9202-4784","authenticated-orcid":true,"given":"Gurpreet","family":"Kindra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linnetie","family":"Mugore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7437-4345","authenticated-orcid":true,"given":"Thomas","family":"Rehle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"key":"pone.0241071.ref001","unstructured":"UNAIDS, 2019 Global HIV statistics. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/UNAIDS_FactSheet_en.pdf"},{"key":"pone.0241071.ref002","volume-title":"South African National HIV Prevalence, Incidence, Behaviour and Communication Survey, 2017","author":"LC Simbayi","year":"2018"},{"key":"pone.0241071.ref003","unstructured":"SANAC (South African National Aids Council) (2017). Let Our Actions Count. South Africa\u2019s National Plan on HIV, TB & AIDS and STIs 2017\u20132022 Pretoria: Department of Health. http:\/\/sanac.org.za\/wp-content\/uploads\/2017\/05\/NSP_FullDocument_FINAL.pdf"},{"key":"pone.0241071.ref004","unstructured":"UNAIDS (Joint United Nations Programme on HIV\/AIDS) (2014a) 90\u201390\u201390 An ambitious treatment target to help end the AIDS epidemic. Geneva: UNAIDS"},{"key":"pone.0241071.ref005","unstructured":"UNAIDS\u2014Global HIV & AIDS statistics\u20142018 fact sheet. https:\/\/www.unaids.org\/en\/resources\/fact-sheet"},{"key":"pone.0241071.ref006","unstructured":"World Health Organization, 2017. HIV drug resistance report 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO."},{"issue":"3","key":"pone.0241071.ref007","first-page":"346","article-title":"HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis [published correction appears in Lancet Infect Dis. 2017 Dec 15;]","volume":"18","author":"RK Gupta","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"pone.0241071.ref008","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/jac\/dkv500","article-title":"Sharp increase in rates of HIV transmitted drug resistance at antenatal clinics in Botswana demonstrates the need for routine surveillance","volume":"71","author":"CF Rowley","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"pone.0241071.ref009","doi-asserted-by":"crossref","first-page":"e42996","DOI":"10.1371\/journal.pone.0042996","article-title":"HIV-1 genetic diversity and transmitted drug resistance mutations among patients from the North, Central and South regions of Angola","volume":"7","author":"JM Afonso","year":"2012","journal-title":"PLoS ONE"},{"key":"pone.0241071.ref010","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S1473-3099(11)70149-9","article-title":"HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study","volume":"11","author":"RL Hamers","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"pone.0241071.ref011","doi-asserted-by":"crossref","first-page":"e0166305","DOI":"10.1371\/journal.pone.0166305","article-title":"Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey","volume":"11","author":"K Steegen","year":"2016","journal-title":"PLoS ONE"},{"issue":"2","key":"pone.0241071.ref012","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/aid.2018.0202","article-title":"Moderate-to-High Levels of Pretreatment HIV Drug Resistance in KwaZulu-Natal Province, South Africa","volume":"35","author":"B Chimukangara","year":"2019","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"3","key":"pone.0241071.ref013","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3851\/IMP3294","article-title":"Provincial and national prevalence estimates of transmitted HIV-1 drug resistance in South Africa measured using two WHO-recommended methods","volume":"24","author":"GM Hunt","year":"2019","journal-title":"Antivir Ther"},{"key":"pone.0241071.ref014","volume-title":"Nelson Mandela\/HSRC Survey of HIV\/AIDS: South African national HIV prevalence, behavioural risks and mass media household survey 2002","author":"O. Shisana","year":"2002"},{"key":"pone.0241071.ref015","volume-title":"South African national HIV prevalence, incidence, behaviour and communication survey, 2005","author":"O. Shisana","year":"2005"},{"key":"pone.0241071.ref016","volume-title":"South African national HIV prevalence, incidence and communication survey, 2008: A turning tide among teenagers?","author":"O. Shisana","year":"2009"},{"key":"pone.0241071.ref017","volume-title":"South African National HIV Prevalence, Incidence and Behaviour Survey, 2012","author":"O. Shisana","year":"2014"},{"key":"pone.0241071.ref018","unstructured":"Stats SA (Statistics South Africa) (2011) Spatial Metadata. Pretoria: Stats SA"},{"issue":"2011","key":"pone.0241071.ref019","first-page":"e28184","article-title":"Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings","volume":"11","author":"Zhiyong Zhou","journal-title":"PLoS one 6"},{"issue":"11","key":"pone.0241071.ref020","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1086\/503914","article-title":"Web Resources for HIV type 1 Genotypic-Resistance Test Interpretation","volume":"42","author":"TF Liu","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"4","key":"pone.0241071.ref021","first-page":"132","article-title":"2017 Update of the Drug Resistance Mutations in HIV-1","volume":"24","author":"AM Wensing","year":"2016","journal-title":"Top Antivir Med"},{"key":"pone.0241071.ref022","unstructured":"World Health Organization, 2019. HIV drug resistance report 2019. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"pone.0241071.ref023","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/QAI.0000000000000790","article-title":"Brief report: Dolutegravir plus abacavir\/lamivudine for the treatment of HIV-1 infection in antiretroviral therapy-naive patients: Week 96 and week 144 results from the SINGLE randomized clinical trial","volume":"70","author":"S Walmsley","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"pone.0241071.ref024","doi-asserted-by":"crossref","first-page":"52735","DOI":"10.1097\/QAI.0000000000000513","article-title":"Risk factors and mortality associated with resistance to first\u2013line antiretroviral therapy: a multicentric cross-sectional and longitudinal analyses","volume":"68","author":"L Pinoges","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0241071.ref025","first-page":"207","article-title":"Transmission of drug resistant HIV and its potential impact on mortality and treatment outcomes in resource-limited settings","volume":"15","author":"V Cambiano","year":"2013","journal-title":"J Infect Dis"},{"key":"pone.0241071.ref026","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/nm.2892","article-title":"Antiretroviral dynamics determines HIV evolution and predicts therapy outcome","volume":"18","author":"DIS Rosenbloom","year":"2012","journal-title":"Nat Med"},{"key":"pone.0241071.ref027","unstructured":"Carmona Maya, SI. Better monitoring HIV treatment adherence in South Africa: Using existing data in new ways. NHLS, NDOH: http:\/\/documents.worldbank.org\/curated\/en\/717241479361814114\/pdf\/110318-BRI-PolicyBriefVLSSAVnovrev-PUBLIC.pdf"},{"issue":"1","key":"pone.0241071.ref028","doi-asserted-by":"crossref","first-page":"a776","DOI":"10.4102\/sajhivmed.v18i1.776","article-title":"Adult antiretroviral therapy guidelines 2017","volume":"18","author":"G Meintjes","year":"2017","journal-title":"S Afr J HIV Med"},{"key":"pone.0241071.ref029","author":"L Mbugbaw","year":"2017","journal-title":"Systematic reviews and meta-analyses used to inform the guidelines on the public health response to pre-treatment HIV drug resistance"},{"key":"pone.0241071.ref030","unstructured":"Guidelines on the public health response to pretreatment HIV drug resistance, July 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"pone.0241071.ref031","unstructured":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach \u20132nd Ed"},{"key":"pone.0241071.ref032","unstructured":"Puren A, Prospective sentinel surveillance of human immunodeficiency virus related drug resistance NICD communicable diseases communiqu\u00e9 March 2016vol25(3)"},{"key":"pone.0241071.ref033","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(12)61038-1","article-title":"Global trends in antiretroviral resistance in treatment-na\u00efve individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and metaregression analysis","volume":"380","author":"R Gupta","year":"2012","journal-title":"Lancet"},{"key":"pone.0241071.ref034","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1093\/jac\/dkx252","article-title":"Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa","volume":"72","author":"G Hunt","year":"2017","journal-title":"Antimicrob Chemotherapy"},{"key":"pone.0241071.ref035","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1086\/587109","article-title":"Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa","volume":"46","author":"VC Marconi","year":"2008","journal-title":"Clin Infect Dis"},{"key":"pone.0241071.ref036","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/QAD.0b013e3283333639","article-title":"Outcomes after virologic failure of first-line ART in South Africa","volume":"24","author":"RA Murphy","year":"2010","journal-title":"AIDS"},{"key":"pone.0241071.ref037","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/QAI.0b013e318228667f","article-title":"Drug resistance and viral tropism in HIV-1 subtype C-infected patients in KwaZulu-Natal, South Africa: implications for future treatment options","volume":"58","author":"A Singh","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0241071.ref038","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1089\/aid.2011.0284","article-title":"Primary drug resistance in South Africa- data from 10 years of surveys","volume":"28","author":"K Manasa","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"pone.0241071.ref039","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/jmv.22143","article-title":"Resistance to antiretroviral drugs in newly diagnosed, young treatment-naive HIV-positive pregnant women in the province of KwaZulu-Natal, South Africa","volume":"83","author":"R Parboosing","year":"2011","journal-title":"J Med Virol"},{"issue":"8","key":"pone.0241071.ref040","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1128\/JCM.00544-14","article-title":"Field study of dried blood spot specimens for HIV-1 drug resistance genotyping","volume":"52","author":"CM Parry","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"Suppl 4","key":"pone.0241071.ref041","doi-asserted-by":"crossref","first-page":"S273","DOI":"10.1093\/cid\/cir982","article-title":"Evaluation of in-house genotyping assay performance using dried blood spot specimens in the Global World Health Organization Laboratory Network","volume":"4","author":"N Parkin","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"pone.0241071.ref042","doi-asserted-by":"crossref","first-page":"S334","DOI":"10.1093\/cid\/cir1017","article-title":"Surveillance of transmitted HIV-1 drug resistance in the Gauteng and KwaZulu Natal regions of South Africa from 2005\u20132009","volume":"54","author":"GM Hunt","year":"2012","journal-title":"Clin Infect Dis"},{"key":"pone.0241071.ref043","unstructured":"World Health Organization, 2014. Surveillance of HIV drugs resistance among adults receiving ART (acquired drug resistance). Geneva, World Health Organization, 2014"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0241071","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T18:47:34Z","timestamp":1604515654000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0241071"}},"subtitle":[],"editor":[{"given":"Giuseppe Vittorio","family":"De Socio","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0241071","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,4]]}}}